Marinomed Biotech AG

Director's Dealing • Feb 5, 2019

Publication Date: 05.02.2019 16:24 EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)

Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

personal data:
responsible party:
name: Invest Unternehmensbeteiligungs Aktiengesellschaft Europaplatz 5a, 4020
Linz (legal person)
--------------------------------------------------------------------------------
reason:
reason: responsible party is a legal person associate to a person with
managerial responsibilities
name and surname: Dr. Gernot Hofer
function: Member of an administrative or supervisory board
--------------------------------------------------------------------------------
issuer information:
name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405
--------------------------------------------------------------------------------
information about deal:
ISIN: ATMARINOMED6
description of the financial instrument: Stock
type: acquisition
date: 01.02.2019; UTC+01:00
market: WIENER BOERSE AG, XWBO
currency: Euro
 price volume
 75 6666
total volume: 6666
total price: 499950
average price: 75
--------------------------------------------------------------------------------

end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service